Cleared Traditional

K800618 - SINGLE

K800618 is the FDA 510(k) clearance for SINGLE by Norton Performance Plastics Corp.. It is a Class 2 Cardiovascular device (product code DQO) cleared through the Traditional 510(k) pathway after a 37-day FDA review.

K800618 · Norton Performance Plastics Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1980
Decision
37d
Days
Class 2
Risk

K800618 is an FDA 510(k) clearance for the SINGLE, 2&3 WAY SOLUTION SETS #14-070 ET. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Norton Performance Plastics Corp. (Mchenry, US). The FDA issued a Cleared decision on April 24, 1980 after a review of 37 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Norton Performance Plastics Corp. devices

Submission Details

510(k) Number K800618 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1980
Decision Date April 24, 1980
Days to Decision 37 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 125d · This submission: 37d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 291
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K800618.
PACKAGE FOR MEDI-TRACE PHYSIOLOGICAL PRE
K801321 · Graphic Controls Corp. · Jun 1980
MEDI-TRACE DISP. LINES FOR PHYSIO. PRESS
K801322 · Graphic Controls Corp. · Jun 1980
EXTENSION LINE
K800622 · Norton Performance Plastics Corp. · Apr 1980
CENTRAL VEIN CATHETERIZATION KIT
K800741 · Medical Components, Inc. · Apr 1980
CENTRAL VENOUS PRESSURE CATHETER
K800461 · Medical Components, Inc. · Mar 1980
WHITE SEALING CAP
K791915 · Quinton, Inc. · Dec 1979